ACCESS SOLUTIONS

Early Access

Depending on the country, it can take months or years before the medicine is commercially available, especially when a pharmaceutical company receives its first regulatory approval. Tanner can help manage this process until they are commercially available in the market.

HOW IT WORKS

Reducing the gap in access and meeting the demand

When a pharmaceutical company receives its first regulatory approval for an innovative medicine, physicians, distributors, patients or ministries of health in other countries often begin requesting access to it.

Depending on the country, it can take months or years before the medicine is commercially available. Similarly, a company may choose not to commercialize the medicine in some countries for various reasons. In most countries, there is an established named patient supply process for fulfilling the demand if the medicine is not commercially available. While some pharmaceutical companies have the means to fulfill requests free of charge, companies may be able to charge for the medicine. Tanner works with pharmaceutical companies to manage all requests for such medicines and satisfy the demand until they are commercially available in the market.

Contact Us

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.